NCT01718093View on ClinicalTrials.gov

A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Type 1 Diabetes
Interventions
DRUG

Sitagliptin

up to 50 mg twice a day

DRUG

Metformin

up to 1000 mg twice a day

DRUG

Sitagliptin + Metformin

up to 50/1000 mg twice a day

Trial Locations (1)

77030

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Baylor College of Medicine

OTHER

NCT01718093 - A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes | Biotech Hunter | Biotech Hunter